Liquid Biopsy Market is Expected to Witness High Growth Owing to Increasing Adoption for Non-invasive Cancer Screening
Liquid biopsy is a non-invasive blood test that detects and analyzes circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and exosomes in blood or other bodily fluids to provide critical health information. It is primarily used to determine tumor mutations, guide treatment decisions, track cancer progression and recurrence. Liquid biopsy helps avoid repeat tumor biopsies that are...
0 Comments 0 Shares